reduced the rate of DNA synthesis b y 26 percent. Syntheses of RNA and of protein (Figs. 4 and 5) were strongly inhibited at the bactericidal concentration of quinacrine; but at the bacteriostatic concentration RNA synthesis was not affected (Fig. 4) , and the incorporation of C14-phenylalanine into the bacterial proteins was reduced by 40 percent (Fig. 5) . In view of the fact that these major biosyntheses were affected by the drug to different extents, the observed effects were not one common result of a general inhibition of the utilization of glucose as a source of energy. Such a mode of action of quinacrine has been suggested (8).
The antimalarial drug, quinacrine, forms a molecular complex with DNA (1) . The acridine ring of the drug molecule is intercalated between the base pairs of double-helical DNA (2) , and the aliphatic diamine side chain apparently bridges complementary DNA strands across the minor groove by ionic attraction to phosphate groups (3) . Consequences of the reaction of quinacrine with DNA are (i) inhibition of the enzymatic hydrolysis of DNA (I), (ii) inhibition of the DNA-dependent DNA and RNA polymerase reactions (3, 4) , (iii) reduction of the frequency of spontaneous or induced mu-' rations at low quinacrine concentrations (5) , and (iv) induction of frameshift mutations at high concentrations (6).
Quinacrine also inhibits the growth of many bacteria, such as Escherichia coli (7). We studied the mode of action of quinacrine with this organism. When the drug was added to E. coli B growing exponentially in a synthetic medium with glucose as the sole source of carbon and energy, turbidimetry at 520 rnp showed that 2 x lo-*M quinacrine reduced the growth rate by 25 percent, while 8 x 10-4M quinacrine decreased the rate by 86 percent, measured over an interval of 1.25 duplication times. Figure 1 shows that 8' X 10-*M quinacrine was strongly bactericidal, but at 2 x lo-4M the drug produced bacteriostasis within one half of a duplication time. Bacteria exposed to this lower concentration of quinacrine for 18 to 24 hours grew into giant filaments (Fig. 2) . Electron microscopy, performed by R. Borasky, revealed a characteristic twisted and braidlike appearance of the cytoplasmic material in the filaments.
Chemical analysis for DNA (Fig. 3 ) revealed that 8 X lo-'M quinacrine inhibited bacterial DNA synthesis completely, while 2 x lo-4M quinacrine 5 . Effect of quinacrine on protein biosynthesis in Escherichia coli. Incorporation of C"-phenylalanine into bacterial proteins was measured by a membrane filter technique. Quinacrine (at indicated concentrations; none in control) and C"-phenylalanine [S &ml (specific activity 6 1 rc/rmolc)] were both added to exponentially growing cultures at time zero. Samples were removed at intervals and immediately diluted with equal volumes of 10 percent trichloroacctic acid (containing 1 percent casamino acids). After 30 minutes a t 2'C, the precipitates from the samples were collected on Millipore filters, washed first with 5 percent trichloroacetic acid (containing casamino acids), and then three times with chloroform to remove residual quinacrine. The filters were placed i n a dioxane-based scintillation fluid, and radioactivities were counted in a NuclearChicago liquid-scintillation counter.
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production of messenger RNA. Undiminished RNA synthesis and appreciable protein synthesis at the bacteriostatic conccniration of 2 X 10-JM quinacrine accounted for the accumulation of large amounts of cytoplasmic material in the filaments after 24 hours (Fig. 2) . This material was organized in distinct segments which were, however, not separated by cross septa. The fact that bacteria exposed to quinacrine failed to initiate events resulting in cell division may be related to the action of the drug upon DNA. By analogy, cells of E s c h e r i c h i a coli in which DNA has reacted with mitomycin C grow within shorter times to shorter filaments which exhibit structural characteristics similar to those we have observed i n the filaments grown in rhe presence of quinacrine (1 1).
Biophysical studies on the nature of the quinacrine-DNA complex (1-3), in hi bit ions of DNA-dependent enzymatic reactions by the drug (I, 3, 4) , as well as our study on the effects of quinacrine in whole bacterial cells are consistent with the view that the mechanism of biological action of the drug is the specific rcnction of quinncrinc with native, double-stranded DNA and that the resulting mode of action is an impairment of DNA replication and, at cytocidal concentrations, of RNA transcription. That quinacrine also exerts its antimalarial effect by acting on the nucleic acids of plasmodia has been postulated by Albert (12) and is supported by observations (13) that the drug inhibits the incorporation of Paorthophosphate into the nucleic acids of plasmodin. 
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